By proceeding, you agree to our Terms of Use and Privacy Policy.
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face.
26-28 July 2022
The most anticipated event of the mRNA calendar, the mRNA-Based Therapeutics Summit is returning for its second year this July as the comprehensive, industry-leading meeting for mRNA experts; your one-stop-shop for all your mRNA-based vaccine and the
Event Ended
USA
Paid
Boston
14-14 September 2022
An intensive 1-day meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development
Virtual
25-28 October 2022
The 5th Annual Targeted Protein Degradation Summit is the world leading industry-dedicated conference that spans the full drug development pipeline from discovery through to the clinic addressing key challenges to make this exciting new modality a th
16-18 November 2022
THE INDUSTRY’S LEADING EVENT IN EUROPE TO ACCELERATE THERAPEUTICS TO MARKET BY EXPEDITING R&D, IMPROVING CMC EFFICIENCY, AND BUILDING NEW PARTNERSHIPS Access new data & case studies from world-renowned speakers and companies across the entire landsca
Hybrid
Vienna
28-01 December 2022
Develop, Validate & Implement Cell-Based & Biophysical Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products at Scale The past twelve months have culminated in an unprecedented level of excitement, investm
29-30 November 2022
An intensive 2-day in person meeting that delves into the latest in vaccine research, platform technologies, analytics and vaccine development & a meeting place for experts working within cutting-edge vaccine research & development.
Germany
Berlin
01-02 December 2022
The formation of nitrosamines as well as other mutagenic impurities in drug substances and drug products maycompromise their safety, quality, and clinical outcomes.
28-30 March 2023
In the context of ever-important gene therapy scale-up to achieve commercial goals and mounting regulatory scrutiny, the 3rd Annual Gene Therapy Comparability Summit is the only event focused on comparability of gene therapy.
07-10 May 2023
Join the TIDES conference from May 7-10, 2023, either in-person or digitally, at the Manchester Grand Hyatt San Diego. This conference is the industry's largest and most prestigious event for accelerating oligo and peptide therapeutics to market, wit
San Diego
10-13 July 2023
Join us at the AAPS Summer Scientific Forum 2023, where we bring together the pharmaceutical industry's leading scientific minds for an unparalleled experience. AAPS stands as the foremost convener of scientific excellence, offering breadth, depth, a
Minneapolis
26-28 July 2023
The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shake
10-13 September 2023
We are delighted to extend a warm invitation to you for the 25th North American Meeting of the International Society for the Study of Xenobiotics (ISSX), taking place at The Westin Boston Seaport District in Boston, Massachusetts, from September 10th
25-25 September 2023
The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurod
Washington, DC
There has been growing interest in targeting kinases such as JAK, TYK, IRAK, SIK, CDK, MEK, ERK, RTK, PLK, PI3K, ALK, MAPK, GSK, LRRK, and more for their role in neurodegeneration, inflammation, cancer, autoimmune, and other disorders. However, targe
26-27 September 2023
Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying nove
While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s c
Cambridge Healthtech Institute's GPCR-Based Drug Discovery conference is now in its 18th year. G protein-coupled receptors (GPCRs), because of their central role in so many cellular processes, are still among the largest class of molecules modulated
Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules
As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an altern
A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are
Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets conference focuses on therapeutic candidates in clinical or earlier stage development that modulate molecules or cellular processes involved in neurodegenerative diseases, especial
27-28 September 2023
Cambridge Healthtech Institute’s annual Lead Generation Strategies conference illuminates the latest approaches used by medicinal, biophysical and computational chemists to discover and develop small molecules (and now slightly larger molecules that
Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge H
Transcription factors are proteins with DNA-binding domains that are involved in gene transcription. They are key cell regulators and alterations in their structure, binding, or activity are often found associated with many abnormalities in cellular
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea
30-02 November 2023
The 6th Targeted Protein Degradation Summit is the premier event for professionals in the field of protein degradation drug development. Returning to Boston in 2023, this summit has established itself as the longest-standing and most comprehensive ga